BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25057856)

  • 21. Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor.
    Chu SY; Yeter K; Kotha R; Pong E; Miranda Y; Phung S; Chen H; Lee SH; Leung I; Bonzon C; Desjarlais JR; Stohl W; Szymkowski DE
    Arthritis Rheumatol; 2014 May; 66(5):1153-64. PubMed ID: 24782179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative differences in CD45 expression unmask functions for CD45 in B-cell development, tolerance, and survival.
    Zikherman J; Doan K; Parameswaran R; Raschke W; Weiss A
    Proc Natl Acad Sci U S A; 2012 Jan; 109(1):E3-12. PubMed ID: 22135465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-cell tolerance.
    Ferry H; Leung JC; Lewis G; Nijnik A; Silver K; Lambe T; Cornall RJ
    Transplantation; 2006 Feb; 81(3):308-15. PubMed ID: 16477212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells.
    Séïté JF; Goutsmedt C; Youinou P; Pers JO; Hillion S
    J Allergy Clin Immunol; 2014 Jan; 133(1):181-8.e1-9. PubMed ID: 24139609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor editing and genetic variability in human autoreactive B cells.
    Lang J; Ota T; Kelly M; Strauch P; Freed BM; Torres RM; Nemazee D; Pelanda R
    J Exp Med; 2016 Jan; 213(1):93-108. PubMed ID: 26694971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
    Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
    J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tracing Self-Reactive B Cells in Normal Mice.
    Nojima T; Reynolds AE; Kitamura D; Kelsoe G; Kuraoka M
    J Immunol; 2020 Jul; 205(1):90-101. PubMed ID: 32414809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens.
    Liu S; Velez MG; Humann J; Rowland S; Conrad FJ; Halverson R; Torres RM; Pelanda R
    J Immunol; 2005 Oct; 175(8):5067-76. PubMed ID: 16210610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of autoreactive B cells: checkpoints and activation.
    Ding C; Yan J
    Arch Immunol Ther Exp (Warsz); 2007; 55(2):83-9. PubMed ID: 17347802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunology. B cell receptor rehabilitation--pausing to reflect.
    King LB; Monroe JG
    Science; 2001 Feb; 291(5508):1503-5. PubMed ID: 11234081
    [No Abstract]   [Full Text] [Related]  

  • 31. Protein kinase Cdelta controls self-antigen-induced B-cell tolerance.
    Mecklenbräuker I; Saijo K; Zheng NY; Leitges M; Tarakhovsky A
    Nature; 2002 Apr; 416(6883):860-5. PubMed ID: 11976686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells.
    Vilen BJ; Burke KM; Sleater M; Cambier JC
    J Immunol; 2002 May; 168(9):4344-51. PubMed ID: 11970976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-reactivity on a spectrum: A sliding scale of peripheral B cell tolerance.
    Tan C; Noviski M; Huizar J; Zikherman J
    Immunol Rev; 2019 Nov; 292(1):37-60. PubMed ID: 31631352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.
    Chen Z; Krinsky A; Woolaver RA; Wang X; Chen SMY; Popolizio V; Xie P; Wang JH
    J Immunol; 2020 Aug; 205(3):830-841. PubMed ID: 32591397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors.
    Kenny JJ; Rezanka LJ; Lustig A; Fischer RT; Yoder J; Marshall S; Longo DL
    J Immunol; 2000 Apr; 164(8):4111-9. PubMed ID: 10754305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen.
    Taylor JJ; Martinez RJ; Titcombe PJ; Barsness LO; Thomas SR; Zhang N; Katzman SD; Jenkins MK; Mueller DL
    J Exp Med; 2012 Oct; 209(11):2065-77. PubMed ID: 23071255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-cell tolerance checkpoints in health and autoimmunity.
    Meffre E; Wardemann H
    Curr Opin Immunol; 2008 Dec; 20(6):632-8. PubMed ID: 18848883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity.
    Doorenspleet ME; Klarenbeek PL; de Hair MJ; van Schaik BD; Esveldt RE; van Kampen AH; Gerlag DM; Musters A; Baas F; Tak PP; de Vries N
    Ann Rheum Dis; 2014 Apr; 73(4):756-62. PubMed ID: 23606709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cell activation versus anergy; the antigen receptor as a molecular switch.
    Cambier JC; Getahun A
    Immunol Lett; 2010 Jan; 128(1):6-7. PubMed ID: 19808046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The five dimensions of B cell tolerance.
    Platt JL; Garcia de Mattos Barbosa M; Cascalho M
    Immunol Rev; 2019 Nov; 292(1):180-193. PubMed ID: 31609002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.